These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1681053)

  • 21. Cilazapril. A review.
    Szucs T
    Drugs; 1991; 41 Suppl 1():18-24. PubMed ID: 1712267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of life in chronic heart failure: cilazapril and captopril versus placebo. Cilazapril-Captopril Multicentre Group.
    Bulpitt CJ; Fletcher AE; Dössegger L; Neiss A; Nielsen T; Viergutz S
    Heart; 1998 Jun; 79(6):593-8. PubMed ID: 10078088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of cilazapril in elderly patients with essential hypertension. A multicenter study.
    Kobrin I; Ben-Ishay D; Bompani R; Dixon R; Hoverman RJ; Jones RW; Kögler P; Sanchez R
    Am J Med; 1989 Dec; 87(6B):33S-36S. PubMed ID: 2532458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical pharmacology of cilazapril.
    Kleinbloesem CH; van Brummelen P; Francis RJ; Wiegand UW
    Drugs; 1991; 41 Suppl 1():3-10. PubMed ID: 1712269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pharmacodynamics and dose-response relationships of the angiotensin converting enzyme inhibitor, cilazapril, in essential hypertension.
    Ajayi AA; Elliott HL; Reid JL
    Br J Clin Pharmacol; 1986 Aug; 22(2):167-75. PubMed ID: 3019375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and haemodynamic effects of the angiotensin converting enzyme inhibitor cilazapril in hypertensive patients with normal and impaired renal function.
    Kloke HJ; Ambros RJ; Van Hamersvelt HW; Wetzels JF; Koene RA; Huysmans FT
    Br J Clin Pharmacol; 1996 Nov; 42(5):615-20. PubMed ID: 8951193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cilazapril: a new non-thiol-containing angiotensin-converting enzyme inhibitor. Worldwide clinical experience in hypertension.
    Kögler P
    Am J Med; 1989 Dec; 87(6B):50S-55S. PubMed ID: 2532461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of the converting enzyme inhibitor cilazapril in normal volunteers and the relationship to enzyme inhibition: development of a mathematical model.
    Francis RJ; Brown AN; Kler L; Fasanella d'Amore T; Nussberger J; Waeber B; Brunner HR
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):32-8. PubMed ID: 2434791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pharmacology of cilazapril.
    Kleinbloesem CH; Van Brummelen P; Francis RJ; Wiegand UW
    Am J Med; 1989 Dec; 87(6B):45S-49S. PubMed ID: 2532460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New, in Austria registered specialty drugs. Inhibace (cilazapril)].
    Töglhofer W
    Wien Klin Wochenschr; 1992; 104(6):178-82. PubMed ID: 1533738
    [No Abstract]   [Full Text] [Related]  

  • 31. The assessment of ACE activity in man following angiotensin I challenges: a comparison of cilazapril, captopril and enalapril.
    Essig J; Belz GG; Wellstein A
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):217S-223S. PubMed ID: 2548551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers.
    Nussberger J; Fasanella d'Amore T; Porchet M; Waeber B; Brunner DB; Brunner HR; Kler L; Brown AN; Francis RJ
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):39-44. PubMed ID: 2434792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of single and consecutive doses of cilazapril and its depressor effects in patients with essential hypertension.
    Shionoiri H; Gotoh E; Miyakawa T; Takasaki I; Oda H; Ueda S; Kaneko Y
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):269S-273S. PubMed ID: 2970854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of single doses of the converting enzyme inhibitor cilazapril in normal volunteers.
    Fasanella d'Amore T; Bussien JP; Nussberger J; Waeber B; Turini GA; Brunner HR; Kler L; Francis RJ
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):26-31. PubMed ID: 2434790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 24 h blood pressure responses of hypertensives to a once-a-day cilazapril regimen.
    Fernandez PG; Bolli P; Lee C
    Can J Cardiol; 1990 Mar; 6(2):53-8. PubMed ID: 2138051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of cilazapril on exercise tolerance and neurohumoral factors in patients with asymptomatic chronic heart failure after myocardial infarction].
    Fujiwara M; Asakuma S; Nakamura T; Nakamura K; Iwasaki T
    J Cardiol; 1995 Nov; 26(5):287-92. PubMed ID: 8523261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between plasma concentration of cilazapril and haemodynamic and hormonal effects in healthy man.
    Burnier M; Mooser V; Nussberger J; Waeber B; Brunner HR
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):189S-197S. PubMed ID: 2527532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of cilazapril on ventricular arrhythmia in patients with congestive heart failure.
    Hattori Y; Atsushi S; Hiroaki F; Toyama J
    Clin Ther; 1997; 19(3):481-6. PubMed ID: 9220212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial.
    Drexler H; Banhardt U; Meinertz T; Wollschläger H; Lehmann M; Just H
    Circulation; 1989 Mar; 79(3):491-502. PubMed ID: 2521816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of cilazapril compared with hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension. Multicentre Study Group.
    Morgan TO
    Am J Med; 1989 Dec; 87(6B):37S-41S. PubMed ID: 2532459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.